Clinical remission among severe asthmatics on monoclonal antibody therapy: real-world outcomes at 2 years.

IF 4.3 3区医学 Q1 RESPIRATORY SYSTEM

ERJ Open Research Pub Date : 2024-12-16 eCollection Date: 2024-11-01 DOI:10.1183/23120541.00261-2024

Fred Fyles, Rachel Burton, Amy Nuttall, Hannah Joplin, Laura Watkins, Hassan Burhan

引用次数: 0

Abstract

Real-world data suggest clinical remission is a feasible treatment goal of monoclonal antibody therapy. Evidence of ongoing response post-12 months may be used to inform treatment decisions. Further work is needed to standardise criteria for remission. https://bit.ly/4cA6TkG.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

ERJ Open Research Medicine-Pulmonary and Respiratory Medicine

CiteScore

6.20

自引率

4.30%

发文量

273

审稿时长

8 weeks

期刊介绍： ERJ Open Research is a fully open access original research journal, published online by the European Respiratory Society. The journal aims to publish high-quality work in all fields of respiratory science and medicine, covering basic science, clinical translational science and clinical medicine. The journal was created to help fulfil the ERS objective to disseminate scientific and educational material to its members and to the medical community, but also to provide researchers with an affordable open access specialty journal in which to publish their work.